Skip to main navigation Skip to search Skip to main content

Central retinal-artery occlusion in a patient with circulating lupus anticoagulant.

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

The circulating lupus anticoagulant is a spontaneously acquired immunoglobulin that has been associated in vivo with an increased risk of thrombotic episodes. We describe the case of a young woman with central retinal-artery occlusion associated with circulating lupus anticoagulant in the absence of systemic lupus erythematosus or any other autoimmune or collagen vascular disease. In cases of central retinal-artery occlusion without apparent cause, the presence of the lupus anticoagulant should be excluded especially in cases that have been exposed to the human immunodeficiency virus.

Original languageEnglish
Pages (from-to)269-271
Number of pages3
JournalAnnals of ophthalmology
Volume21
Issue number7
StatePublished - 1 Jan 1989

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint

Dive into the research topics of 'Central retinal-artery occlusion in a patient with circulating lupus anticoagulant.'. Together they form a unique fingerprint.

Cite this